N. Shiraiwa

Characterization of three cinnamyl alcohol dehydrogenases from Carthamus tinctorius

T. Umezawa, Shiro Suzuki, T. Hattori, 2013 .

Ceritinib in Japanese patients with anaplastic lymphoma kinase (ALK)+ non-small cell lung cancer: interim analysis results of a post-marketing surveillance study

H. Kaneda, M. Ochi, N. Shiraiwa, 2020, Scientific Reports.

A Retrospective, Multicenter, Observational Study to Evaluate Clinical Outcomes of Lorlatinib After Alectinib in Patients With ALK-Positive NSCLC in Japan

K. Imaizumi, M. Nishio, H. Kenmotsu, 2023, JTO clinical and research reports.

Real‐world study of next‐generation sequencing diagnostic biomarker testing for patients with lung cancer in Japan

K. Nishio, M. Nishio, Toshiaki Takahashi, 2023, Cancer science.

Effectiveness of crizotinib in patients with ROS1-positive non-small-cell lung cancer: real-world evidence in Japan.

B. Emir, N. Nogami, A. Nakamura, 2023, Future Oncology.